Our Mammalian-Derived Exosome Engineering Services for CAR-T Support provide a flexible solution rooted in advanced cargo incorporation, surface modification, and exosome-based design. Leveraging mammalian exosomes as customizable carriers, this platform shifts conventional cell-based treatments toward potent cell-free systems. By circumventing the constraints associated with living cells, our engineered exosomes deliver safer, more deeply penetrating, and finely tunable assistance for CAR-T therapies, thereby propelling your next-generation immunotherapeutic projects forward.
